LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
nulllengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
nulllengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
nulllengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100002-5 | Specimen care is maintained | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Specimen care is maintained | null | null | ACTIVE | 2.72 | 2.72 |
100003-3 | Team communication is maintained throughout care | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Team communication is maintained throughout care | null | null | ACTIVE | 2.72 | 2.72 |
100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Demonstrates knowledge of the expected psychosocial responses to the procedure | null | null | ACTIVE | 2.72 | 2.72 |
100005-8 | Demonstrates knowledge of nutritional management related to the procedure | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Demonstrates knowledge of nutritional management related to the procedure | null | null | ACTIVE | 2.72 | 2.72 |
100006-6 | Demonstrates knowledge of medication management | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Demonstrates knowledge of medication management | null | null | ACTIVE | 2.72 | 2.72 |
100007-4 | Demonstrates knowledge of pain management | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Demonstrates knowledge of pain management | null | null | ACTIVE | 2.72 | 2.72 |
10000-8 | R wave duration.lead AVR | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead AVR | null | null | ACTIVE | 1.0i | 2.48 |
100008-2 | Demonstrates knowledge of wound management | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Demonstrates knowledge of wound management | null | null | ACTIVE | 2.72 | 2.72 |
100009-0 | Demonstrates knowledge of the procedure and expected results | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Demonstrates knowledge of the procedure and expected results | null | null | ACTIVE | 2.72 | 2.72 |
100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to procedure equipment, medical supplies, or instrumentation | null | null | ACTIVE | 2.72 | 2.72 |
100011-6 | No injury related to an electrical source | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to an electrical source | null | null | ACTIVE | 2.72 | 2.72 |
100012-4 | Participates in decisions affecting the patient's plan of care | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Participates in decisions affecting the patient's plan of care | null | null | ACTIVE | 2.72 | 2.72 |
100013-2 | Participates in the discharge process | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Participates in the discharge process | null | null | ACTIVE | 2.72 | 2.72 |
100014-0 | Psychosocial health is maintained at or improved from baseline | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | Psychosocial health is maintained at or improved from baseline | null | null | ACTIVE | 2.72 | 2.72 |
100015-7 | No injury related to positioning due to care or procedure | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to positioning due to care or procedure | null | null | ACTIVE | 2.72 | 2.72 |
10001-6 | R wave duration.lead I | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead I | null | null | ACTIVE | 1.0i | 2.48 |
100016-5 | No injury related to a laser source | Find | Pt | ^Patient | Ord | null | SURVEY.PNDS | 4 | No injury related to a laser source | null | null | ACTIVE | 2.72 | 2.72 |
100017-3 | Perioperative nursing data set outcomes panel | - | Pt | ^Patient | - | null | PANEL.SURVEY.PNDS | 4 | Perioperative nursing data set outcomes panel [PNDS] | null | null | ACTIVE | 2.72 | 2.72 |
100018-1 | Note | Find | Pt | {Setting} | Doc | null | DOC.ONTOLOGY | 2 | Hospice care Note | null | null | ACTIVE | 2.72 | 2.72 |
100019-9 | ALK gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100020-7 | GNA11 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100021-5 | GNAQ gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100022-3 | IDH1 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100023-1 | IDH2 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
10002-4 | R wave duration.lead II | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead II | null | null | ACTIVE | 1.0i | 2.48 |
100024-9 | SETBP1 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100025-6 | SRSF2 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100026-4 | MET gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100027-2 | SMAD4 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100028-0 | FBXW7 gene targeted mutation analysis | Prid | Pt | Bld/Tiss | Nom | null | MOLPATH.MUT | 1 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | null | null | ACTIVE | 2.72 | 2.72 |
100029-8 | Cancer related multigene analysis | Find | Pt | Plas.cfDNA | Doc | null | MOLPATH | 1 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method | null | null | ACTIVE | 2.72 | 2.72 |
100030-6 | Axis I: Temporal aspects score | Score | Pt | ^Patient | Qn | null | SURVEY.PAIN | 4 | Axis I: Temporal aspects score [Mainz Pain Staging System] | null | null | ACTIVE | 2.72 | 2.72 |
100031-4 | Axis II: Spatial aspects score | Score | Pt | ^Patient | Qn | null | SURVEY.PAIN | 4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | null | null | ACTIVE | 2.72 | 2.72 |
10003-2 | R wave duration.lead III | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead III | null | null | ACTIVE | 1.0i | 2.48 |
100032-2 | Axis III: Drug taking behavior score | Score | Pt | ^Patient | Qn | null | SURVEY.PAIN | 4 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | null | null | ACTIVE | 2.72 | 2.72 |
100033-0 | Axis IV: Utilization of the health care system score | Score | Pt | ^Patient | Qn | null | SURVEY.PAIN | 4 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | null | null | ACTIVE | 2.72 | 2.72 |
100034-8 | Provider of automated external defibrillator use | Type | Pt | ^Patient | Nom | null | TRAUMA | 2 | Provider of automated external defibrillator use | null | null | ACTIVE | 2.72 | 2.72 |
100035-5 | Exam finding location | Find | Pt | Chest | Nom | null | H&P.PX | 2 | Exam finding location of Chest | null | null | ACTIVE | 2.72 | 2.72 |
100036-3 | Exam finding location | Find | Pt | Lung | Nom | null | H&P.PX | 2 | Exam finding location of Lung | null | null | ACTIVE | 2.72 | 2.72 |
100037-1 | Patient contact disposition | Type | Pt | EMS unit | Nom | null | TRAUMA | 2 | Patient contact disposition EMS unit | null | null | ACTIVE | 2.72 | 2.72 |
100038-9 | Patient evaluation disposition | Type | Pt | EMS unit | Nom | null | TRAUMA | 2 | Patient evaluation disposition EMS unit | null | null | ACTIVE | 2.72 | 2.72 |
100039-7 | Crew disposition for patient care | Type | Pt | EMS unit | Nom | null | TRAUMA | 2 | Crew disposition for patient care EMS unit | null | null | ACTIVE | 2.72 | 2.72 |
10004-0 | R wave duration.lead V1 | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead V1 | null | null | ACTIVE | 1.0i | 2.48 |
100040-5 | Patient transport disposition | Type | Pt | EMS unit | Nom | null | TRAUMA | 2 | Patient transport disposition EMS unit | null | null | ACTIVE | 2.72 | 2.72 |
100041-3 | Aminoglycoside | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Aminoglycoside [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100042-1 | Atovaquone | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Atovaquone [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100043-9 | Azithromycin+Ethambutol | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Azithromycin+Ethambutol [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100044-7 | Cefcapene | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Cefcapene [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100045-4 | Cefozopran | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Cefozopran [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100046-2 | Cefquinome | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Cefquinome [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100047-0 | Cefteram | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Cefteram [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100048-8 | Clarithromycin+Ethambutol | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Clarithromycin+Ethambutol [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100049-6 | Eravacycline | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Eravacycline [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100050-4 | Erythromycin+Ethambutol | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Erythromycin+Ethambutol [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100051-2 | Ethambutol+rifAMPin | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Ethambutol+rifAMPin [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100052-0 | Flomoxef | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Flomoxef [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100053-8 | Fluoroquinolone | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Fluoroquinolone [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100054-6 | Gamithromycin | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Gamithromycin [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100055-3 | Optochin | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Optochin [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100056-1 | Panipenem | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Panipenem [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
10005-7 | R wave duration.lead V2 | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead V2 | null | null | ACTIVE | 1.0i | 2.48 |
100057-9 | Prothionamide | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Prothionamide [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100058-7 | Prulifloxacin | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Prulifloxacin [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100059-5 | Rifapentine | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Rifapentine [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100060-3 | Tildipirosin | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Tildipirosin [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100061-1 | Tosufloxacin | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Tosufloxacin [Susceptibility] | null | null | ACTIVE | 2.72 | 2.72 |
100062-9 | Standard Dermatology Outcome Measures panel | - | Pt | ^Patient | - | null | PANEL.CLIN | 2 | Standard Dermatology Outcome Measures panel | null | null | ACTIVE | 2.72 | 2.72 |
100063-7 | Primary skin concern | Find | Pt | ^Patient | Nom | null | CLIN | 2 | Primary skin concern | null | null | ACTIVE | 2.72 | 2.72 |
100064-5 | Itch severity | Find | RptPeriod | ^Patient | Ord | null | CLIN | 2 | Itch severity Reporting Period - Reported | null | null | ACTIVE | 2.72 | 2.72 |
10006-5 | R wave duration.lead V3 | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead V3 | null | null | ACTIVE | 1.0i | 2.48 |
100065-2 | Satisfied with treatment | Find | Pt | ^Patient | Ord | null | CLIN | 2 | Satisfied with treatment | null | null | ACTIVE | 2.72 | 2.72 |
100066-0 | Specular microscopy panel | - | Pt | Eye | - | null | PANEL.EYE | 2 | Specular microscopy panel | null | null | TRIAL | 2.72 | 2.72 |
100067-8 | Image magnification | Len | Pt | Eye | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Eye Image magnification | null | null | TRIAL | 2.72 | 2.72 |
100068-6 | Fixation point | Angle | Pt | Eye.right | Nom | null | EYE.SPECULAR MICROSCOPY | 2 | Right eye Fixation point [Angle] | null | null | TRIAL | 2.72 | 2.72 |
100069-4 | Fixation point | Angle | Pt | Eye.left | Nom | null | EYE.SPECULAR MICROSCOPY | 2 | Left eye Fixation point [Angle] | null | null | TRIAL | 2.72 | 2.72 |
100070-2 | Cell density | Naric | Pt | Cornea.right | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Cell density | null | null | TRIAL | 2.72 | 2.72 |
100071-0 | Cell density | Naric | Pt | Cornea.left | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Left cornea Cell density | null | null | TRIAL | 2.72 | 2.72 |
100072-8 | Coefficient of variation | ArLen | Pt | Cornea.right | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Coefficient of variation | null | null | TRIAL | 2.72 | 2.72 |
10007-3 | R wave duration.lead V4 | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead V4 | null | null | ACTIVE | 1.0i | 2.48 |
100073-6 | Coefficient of variation | ArLen | Pt | Cornea.left | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Left cornea Coefficient of variation | null | null | TRIAL | 2.72 | 2.72 |
100074-4 | Hexagonality | RelRto | Pt | Cornea.right | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Hexagonality | null | null | TRIAL | 2.72 | 2.72 |
100075-1 | Hexagonality | RelRto | Pt | Cornea.left | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Left cornea Hexagonality | null | null | TRIAL | 2.72 | 2.72 |
100076-9 | Endothelial cells counted | Num | Pt | Cornea.right | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Endothelial cells counted | null | null | TRIAL | 2.72 | 2.72 |
100077-7 | Endothelial cells counted | Num | Pt | Cornea.left | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Left cornea Endothelial cells counted | null | null | TRIAL | 2.72 | 2.72 |
100078-5 | Endothelial cell area.min | Area | Pt | Cornea.right | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Endothelial cell area.min | null | null | TRIAL | 2.72 | 2.72 |
100079-3 | Endothelial cell area.min | Area | Pt | Cornea.left | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Left cornea Endothelial cell area.min | null | null | TRIAL | 2.72 | 2.72 |
100080-1 | Endothelial cell area.max | Area | Pt | Cornea.right | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Endothelial cell area.max | null | null | TRIAL | 2.72 | 2.72 |
10008-1 | R wave duration.lead V5 | Time | Pt | Heart | Qn | null | EKG.MEAS | 2 | R wave duration in lead V5 | null | null | ACTIVE | 1.0i | 2.48 |
100081-9 | Endothelial cell area.max | Area | Pt | Cornea.left | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Left cornea Endothelial cell area.max | null | null | TRIAL | 2.72 | 2.72 |
100082-7 | Endothelial cell area.mean | Area | Pt | Cornea.right | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Endothelial cell area.mean | null | null | TRIAL | 2.72 | 2.72 |
100083-5 | Endothelial cell area.mean | Area | Pt | Cornea.left | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Left cornea Endothelial cell area.mean | null | null | TRIAL | 2.72 | 2.72 |
100084-3 | Cell area.standard deviation | Area | Pt | Cornea.right | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Cell area.standard deviation | null | null | TRIAL | 2.72 | 2.72 |
100085-0 | Cell area.standard deviation | Area | Pt | Cornea.left | Qn | null | EYE.SPECULAR MICROSCOPY | 2 | Left cornea Cell area.standard deviation | null | null | TRIAL | 2.72 | 2.72 |
100086-8 | Analysis method | Type | Pt | Cornea.right | Nom | null | EYE.SPECULAR MICROSCOPY | 2 | Right cornea Type of Analysis method by Specular microscopy | null | null | TRIAL | 2.72 | 2.72 |
100087-6 | Toxocara canis 24-35kD Ab.IgG | PrThr | Pt | Ser | Ord | null | MICRO | 1 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot | null | null | ACTIVE | 2.72 | 2.72 |
100088-4 | Taenia solium larva Ab bands panel | - | Pt | Ser | - | null | PANEL.MICRO | 1 | Taenia solium larva Ab bands panel - Serum by Immunoblot | null | null | ACTIVE | 2.72 | 2.72 |
100089-2 | Taenia solium larva 6-8kD Ab | PrThr | Pt | Ser | Ord | null | MICRO | 1 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot | null | null | ACTIVE | 2.72 | 2.72 |
1000-9 | DBG Ab | PrThr | Pt | Ser/Plas^BPU | Ord | null | BLDBK | 1 | DBG Ab [Presence] in Serum or Plasma from Blood product unit | null | null | ACTIVE | 1.0 | 2.56 |
100090-0 | Taenia solium larva 45kD Ab | PrThr | Pt | Ser | Ord | null | MICRO | 1 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot | null | null | ACTIVE | 2.72 | 2.72 |
100091-8 | Trypanosoma cruzi Ab | ACnc | Pt | Ser | Qn | null | MICRO | 1 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay | null | null | ACTIVE | 2.72 | 2.72 |
End of preview. Expand
in Dataset Viewer.
README.md exists but content is empty.
Use the Edit dataset card button to edit it.
- Downloads last month
- 32